留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

同型半胱氨酸临床应用的研究进展

林妮 柯渠青 蒋玲燕 欧兰芝 刘蝶梅 吴玉颜 杜庆锋

林妮, 柯渠青, 蒋玲燕, 欧兰芝, 刘蝶梅, 吴玉颜, 杜庆锋. 同型半胱氨酸临床应用的研究进展[J]. 中华全科医学, 2021, 19(8): 1358-1361. doi: 10.16766/j.cnki.issn.1674-4152.002060
引用本文: 林妮, 柯渠青, 蒋玲燕, 欧兰芝, 刘蝶梅, 吴玉颜, 杜庆锋. 同型半胱氨酸临床应用的研究进展[J]. 中华全科医学, 2021, 19(8): 1358-1361. doi: 10.16766/j.cnki.issn.1674-4152.002060
LIN Ni, KE Qu-qing, JIANG Ling-yan, OU Lan-zhi, LIU Die-mei, WU Yu-yan, DU Qing-feng. The clinical application value of homocysteine[J]. Chinese Journal of General Practice, 2021, 19(8): 1358-1361. doi: 10.16766/j.cnki.issn.1674-4152.002060
Citation: LIN Ni, KE Qu-qing, JIANG Ling-yan, OU Lan-zhi, LIU Die-mei, WU Yu-yan, DU Qing-feng. The clinical application value of homocysteine[J]. Chinese Journal of General Practice, 2021, 19(8): 1358-1361. doi: 10.16766/j.cnki.issn.1674-4152.002060

同型半胱氨酸临床应用的研究进展

doi: 10.16766/j.cnki.issn.1674-4152.002060
基金项目: 

国家重点研发计划子课题 2020YFC2006401

详细信息
    通讯作者:

    杜庆锋,E-mail:nhyyqk@126.com

  • 中图分类号: R446

The clinical application value of homocysteine

  • 摘要: 同型半胱氨酸(homocysteine,Hcy)产生于必需氨基酸甲硫氨酸向半胱氨酸转化的过程,并通过甲基化作用参与脱氧核糖核酸(DNA)代谢。近年来诸多研究表明,血Hcy水平与多种疾病有直接或间接关系,如动脉硬化、心血管疾病、高血压、神经系统疾病、糖尿病、恶性肿瘤、妊娠期疾病、眼部疾病和骨质疏松等。人体血浆中Hcy的正常范围是5~15 μmol/L,>15 μmol/L为高Hcy血症(hyper homocysteine, HHcy)。基因突变,叶酸、维生素B6、B12缺乏导致的营养不良及高甲硫氨酸的饮食模式均是Hcy升高的常见原因。研究证实,亚甲基四氢叶酸还原酶(methylenetetrahydrofolate reductase, MTHFR)C677T基因多态性与血浆Hcy水平升高的易感性相关。而中国人群中MTHFR 677TT基因型表达显著高于其他种族。血清Hcy水平升高的致病机理可能为:促进炎症和血管钙化;脂质过氧化和抗氧化过程受损;刺激活性氧的产生,诱导氧化应激和血管功能障碍;内皮细胞毒性及功能障碍;抑制神经递质释放等。其他致病机制仍有待进一步研究。Hcy水平在预测疾病风险、控制疾病并发症、影响疾病转归中有重要价值。中国人口总体HHcy患病率较高,且地域差异显著。随着年龄增大,患病率也随之升高。Hcy水平监测有利于疾病的早发现、早诊断及严重并发症的早预防。结合最新文献报道,文章探讨Hcy致病机制及其与疾病的关系,为Hcy的临床应用提供参考。

     

  • [1] 徐炳欣, 赵艳, 段淑娟, 等. 亚甲基四氢叶酸还原酶a1298c基因多态性检测在高同型半胱氨酸血症治疗中的价值[J]. 中华全科医学, 2020, 18(9): 1470-1473. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202009012.htm
    [2] MOON H, KO H, KIM A. Hyperhomocysteinemia concurrent with metabolic syndrome is independently associated with chronic kidney disease among Community-Dwelling adults in an urban korean population. [J]. Int J Env Res Pub He, 2020, 17(18): 6810. doi: 10.3390/ijerph17186810
    [3] XU R, HUANG F, WANG Y, et al. Gender- and age-related differences in homocysteine concentration: A cross-sectional study of the general population of China[J]. Sci Rep-Uk, 2020, 10(1): 17401. doi: 10.1038/s41598-020-74596-7
    [4] LU S S, XIE J, SU C Q, et al. Plasma homocysteine levels and intracranial plaque characteristics: Association and clinical relevance in ischemic stroke[J]. Bio Med Central, 2018, 18(1): 200. doi: 10.1186%2Fs12883-018-1203-4.pdf
    [5] ZOU J, CHEN Z, LIANG C, et al. Trefoil factor 3, cholinesterase and homocysteine: Potential predictors for Parkinson's disease dementia and vascular parkinsonism dementia in advanced stage[J]. Aging Dis, 2018, 9(1): 51-65. doi: 10.14336/AD.2017.0416
    [6] SANTOTORIBIO J D, DEL V L, GARCÍA-DE L T A, et al. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion[J]. PLoS One, 2019, 14(9): e0222616. http://www.researchgate.net/publication/336025378_The_diagnostic_value_of_pleural_fluid_homocysteine_in_malignant_pleural_effusion
    [7] CHANG Y, LI Y, GUO X, et al. The prevalence of hypertension accompanied by high homocysteine and its risk factors in a rural population: A Cross-Sectional study from northeast China[J]. Int J Env Res Pub He, 2017, 14(4): 376. doi: 10.3390/ijerph14040376
    [8] SUN P, WANG Q, ZHANG Y, et al. Association between homocysteine level and blood pressure traits among Tibetans: A cross-sectional study in China[J]. Medicine, 2019, 98(27): e16085. doi: 10.1097/MD.0000000000016085
    [9] 王红, 康小琴, 谢文博, 等. 血浆同型半胱氨酸和高敏c反应蛋白水平与h型高血压患者左心室肥厚的关系[J]. 中国医药, 2019, 14(11): 1606-1609. doi: 10.3760/j.issn.1673-4777.2019.11.002
    [10] ZHOU F, HOU D, WANG Y, et al. Evaluation of H-type hypertension prevalence and its influence on the risk of increased carotid intima-media thickness among a high-risk stroke population in Hainan Province, China[J]. Medicine (Baltimore), 2020, 99(35): e21953. doi: 10.1097/MD.0000000000021953
    [11] 何菁, 蒋利, 顾北音, 等. 高血压患者血浆同型半胱氨酸与血压变异的相关性[J]. 中国临床医学, 2017, 24(6): 920-923. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX201706017.htm
    [12] WANG W W, WANG X S, ZHANG Z R, et al. A meta-analysis of folic acid in combination with anti-Hypertension drugs in patients with hypertension and hyperhomocysteinemia[J]. Front Pharmacol, 2017, 31(8): 585. doi: 10.3389/fphar.2017.00585/pdf
    [13] WANG Y, JIN Y, WANG Y, et al. The effect of folic acid in patients with cardiovascular disease: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2019, 98(37): e17095. doi: 10.1097/MD.0000000000017095
    [14] CHRYSANT S G, CHRYSANT G S. The current status of homocysteine as a risk factor for cardiovascular disease: A mini review[J]. Expert review of cardiovascular therapy, 2018, 16(8): 559-565. doi: 10.1080/14779072.2018.1497974
    [15] HASAN T, ARORA R, BANSAL A K, et al. Disturbed homocysteine metabolism is associated with cancer[J]. Exp Mol Med, 2019, 51(2): 1-13. http://www.onacademic.com/detail/journal_1000041601204699_5db2.html
    [16] XU J, ZHAO X, SUN S, et al. Homocysteine and digestive tract cancer risk: A dose-response meta-analysis[J]. J Oncol, 2018, 2018(18): 3720684. http://www.onacademic.com/detail/journal_1000041641508099_855f.html
    [17] HOUGHTON S C, ELIASSEN A H, ZHANG S M, et al. Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women[J]. Breast Cancer Res Treat, 2019, 176(1): 191-203. doi: 10.1007/s10549-019-05223-x
    [18] 李亚芹, 闫勇, 张倡誌, 等. 胃癌患者化疗前后血清β2微球蛋白、视黄醇结合蛋白、Hcy水平及T淋巴细胞亚群的变化及临床意义[J]. 癌症进展, 2019, 17(5): 585-588. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ201905024.htm
    [19] PLATT D E, HARIRI E, SALAMEH P, et al. Type Ⅱ diabetes mellitus and hyperhomocysteinemia: A complex interaction[J]. Diabetol Metab Syndr, 2017, 2017(9): 19. http://www.onacademic.com/detail/journal_1000039897110410_b992.html
    [20] MUZUROV I C ' E, KRALJEV I C ' I, SOLAK M, et al. Homocysteine and diabetes: Role in macrovascular and microvascular complications[J]. J Diabetes Complications, 2021, 35(3): 107834. doi: 10.1016/j.jdiacomp.2020.107834
    [21] RUJASWINI T, DEVANANDAN P, RANADHEER C P, et al. A review on association of serum homocysteine in diabetic neuropathy[J]. Drug Invention Today, 2018, 10(2): 154-156. http://www.researchgate.net/profile/Praveen_Devanandan/publication/324965481_A_review_on_association_of_serum_homocysteine_in_diabetic_neuropathy/links/5aee9f970f7e9b01d3e18cbb/A-review-on-association-of-serum-homocysteine-in-diabetic-neuropathy.pdf
    [22] 曾金海. 同型半胱氨酸及血尿酸与2型糖尿病血管并发症的关系[J]. 中国临床新医学, 2017, 10(8): 786-788. doi: 10.3969/j.issn.1674-3806.2017.08.22
    [23] WANG X, ZHOU Y, ZHANG M, et al. The methylenetetrahydrofolate reductase genotype 677CT and non-alcoholic fatty liver disease have a synergistic effect on the increasing homocysteine levels in subjects from Chongqing, China[J]. Genes Dis, 2019, 6(1): 88-95. doi: 10.1016/j.gendis.2018.07.003
    [24] 王传池, 胡镜清, 彭锦, 等. H型高血压脑卒中高发的病机探析[J]. 中国中医基础医学杂志, 2017, 23(2): 161-163. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201702007.htm
    [25] GAIDAY A N, TUSSUPKALIYEV A B, BERMAGAMBETOVA S K, et al. Effect of homocysteine on pregnancy: A systematic review[J]. Chem Biol Interact, 2018, 2018(293): 70-76. http://www.researchgate.net/profile/Andrey_Gaiday2/publication/326574384_Effect_of_homocysteine_on_pregnancy_A_systematic_review/links/5b9bd8bd45851574f7cb315b/Effect-of-homocysteine-on-pregnancy-A-systematic-review.pdf
    [26] AZZINI E, RUGGERI S, POLITO A. Homocysteine: Its possible emerging role in At-Risk population groups[J]. Int J Mol Sci, 2020, 21(4): 1421. doi: 10.3390/ijms21041421
    [27] MAGED A M, SAAD H, MESHAAL H, et al. Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation[J]. Arch Gynecol Obstet, 2017, 296(3): 475-482. doi: 10.1007/s00404-017-4457-y
    [28] SUN F, QIAN W, ZHANG C, et al. Correlation of maternal serum homocysteine in the first trimester with the development of gestational hypertension and preeclampsia[J]. Med Sci Monit, 2017, 23(11): 5396-5401. http://www.onacademic.com/detail/journal_1000040879149110_3f79.html
    [29] 乐元芬. 胎儿生长受限孕妇妊娠晚期血清同型半胱氨酸表达水平及意义[J]. 中国妇幼保健, 2017, 32(6): 1184-1185. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201706023.htm
    [30] KONG X, MA X, ZHANG C, et al. Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort[J]. Int Urol Nephrol, 2017, 49(4): 661-667. doi: 10.1007/s11255-016-1452-3
    [31] ZHOU Y F, GUAN Y F. Hyperhomocysteinemia and kidney diseases[J]. Sheng Li Xue Bao, 2018, 70(6): 607-611. http://www.ncbi.nlm.nih.gov/pubmed/30560269
    [32] KUANG Z M, WANG Y, FENG S J, et al. Association between plasma homocysteine and microalbuminuria in untreated patients with essential hypertension: A case-control study[J]. Kidney Blood Press Res, 2017, 42(6): 1303-1311. doi: 10.1159/000486013
    [33] 范斌, 李晓玉, 张萍. 老年男性血浆同型半胱氨酸水平与髋关节骨密度的相关性分析[J]. 中国医药导报, 2021, 18(3): 101-104. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202103025.htm
    [34] BEHERA J, BALA J, NURU M, et al. Homocysteine as a pathological biomarker for bone disease[J]. J Cell Physiol, 2017, 232(10): 2704-2709. doi: 10.1002/jcp.25693
    [35] OHISHI T, FUJITA T, NISHIDA T, et al. Factors influencing serum homocysteine levels in postmenopausal osteoporotic females - comparison to urinary collagen crosslinks[J]. Endocr Res, 2019, 44(3): 117-125. doi: 10.1080/07435800.2019.1577892
    [36] 董丽娟, 高飞. 骨密度及骨代谢指标与同型半胱氨酸关系的研究进展[J]. 中国骨质疏松杂志, 2020, 26(8): 1241-1244. doi: 10.3969/j.issn.1006-7108.2020.08.031
    [37] LEI X, ZENG G, ZHANG Y, et al. Association between homocysteine level and the risk of diabetic retinopathy: A systematic review and meta-analysis[J]. Diabetol Metab Syndr, 2018, 2018(10): 61. http://www.onacademic.com/detail/journal_1000040484067510_990c.html
    [38] PINNA A, ZACCHEDDU F, BOSCIA F, et al. Homocysteine and risk of age-related macular degeneration: A systematic review and meta-analysis[J]. Acta Ophthalmol, 2018, 96(3): e269-e276. doi: 10.1111/aos.13343
    [39] JENKINS D, SPENCE J D, GIOVANNUCCI E L, et al. Supplemental vitamins and minerals for CVD prevention and treatment[J]. J Am Coll Cardiol, 2018, 71(22): 2570-2584. doi: 10.1016/j.jacc.2018.04.020
    [40] SPENCE J D. Nutrition and risk of stroke[J]. Nutrients, 2019, 11(3): 647. doi: 10.3390/nu11030647
    [41] SPENCE J D, YI Q, HANKEY G J. B vitamins in stroke prevention: Time to reconsider[J]. Lancet Neurol, 2017, 16(9): 750-760. doi: 10.1016/S1474-4422(17)30180-1
    [42] SPENCE J D, HACHINSKI V. B vitamins for stroke prevention: Interaction of low platelet count and high plasma total homocysteine[J]. J Am Coll Cardiol, 2018, 71(19): 2147-2148. doi: 10.1016/j.jacc.2018.03.024
    [43] LIND M V, LAURITZEN L, KRISTENSEN M, et al. Effect of folate supplementation on insulin sensitivity and type 2 diabetes: A meta-analysis of randomized controlled trials[J]. Am J Clin Nutr, 2019, 109(1): 29-42. doi: 10.1093/ajcn/nqy234
    [44] KAGAWA Y, HIRAOKA M, KAGEYAMA M, et al. Medical cost savings in Sakado City and worldwide achieved by preventing disease by folic acid fortification[J]. Congenit Anom (Kyoto), 2017, 57(5): 157-165. doi: 10.1111/cga.12215
  • 加载中
计量
  • 文章访问数:  183
  • HTML全文浏览量:  343
  • PDF下载量:  22
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-12-21
  • 网络出版日期:  2022-02-16

目录

    /

    返回文章
    返回